Us Pantoprazole Sodium (CAS 138786-67-1) Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Pantoprazole Sodium (CAS 138786-67-1) Market was valued at USD 4.12 Billion in 2022 and is projected to reach USD 6.75 Billion by 2030, growing at a CAGR of 7.20% from 2024 to 2030.
The U.S. Pantoprazole Sodium (CAS 138786-67-1) market has witnessed significant developments recently, reflecting the dynamic nature of the pharmaceutical industry. Notably, Granules India Limited received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-Release Tablets USP in 20 mg and 40 mg strengths. These tablets are bioequivalent and therapeutically equivalent to Protonix Delayed-Release Tablets by Wyeth Pharmaceuticals LLC. This approval expands Granules India's portfolio to 64 ANDA approvals, underscoring its growing presence in the U.S. market.
Pantoprazole Sodium is primarily used for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and management of pathological hypersecretory conditions, including Zollinger-Ellison syndrome. The annual U.S. market for Pantoprazole Tablets is approximately $233 million, indicating a substantial demand for this medication.
However, the market faces challenges. In September 2024, the Central Drugs Standard Control Organization (CDSCO) reported that 53 commonly used medicines, including Pantoprazole, failed quality tests. Such findings raise concerns about the safety and efficacy of widely used medications, potentially impacting consumer trust and market dynamics.
From a personal perspective, as someone who has closely followed the pharmaceutical industry, it's evident that the approval of generic formulations like Granules India's Pantoprazole Sodium tablets plays a crucial role in making essential medications more accessible and affordable. However, ensuring stringent quality control is paramount to maintain patient trust and safety.
In summary, while the U.S. Pantoprazole Sodium market is expanding, driven by approvals of generic formulations and a significant patient base requiring treatment for acid-related disorders, maintaining high-quality standards remains essential to sustain growth and consumer confidence.
Get an In-Depth Research Analysis of the Global Pantoprazole Sodium (CAS 138786-67-1) Market Size And Forecast [2025-2032]
Shandong Renhetang Pharmaceutical
Takeda GmbH
Pfizer
Lee Pharma Ltd.
Luye Pharma Group
Liaoning Nirvana Pharmaceutical
Hubei Weisen Pharmaceutical
Mreeo Pharmaceutical
Teva Pharmaceutical
Dr. Reddys Laboratories
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Pantoprazole Sodium (CAS 138786-67-1) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Pantoprazole Sodium (CAS 138786-67-1) Market
Tablets
Oral Suspension
Injectable Solutions
Oral
Intravenous
Gastroesophageal Reflux Disease (GERD)
Peptic Ulcers
Zollinger-Ellison Syndrome
Pediatric Patients
Adult Patients
Geriatric Patients
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pantoprazole Sodium (CAS 138786-67-1) Market Research Analysis
1. Introduction of the Global Pantoprazole Sodium (CAS 138786-67-1) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Pantoprazole Sodium (CAS 138786-67-1) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Pantoprazole Sodium (CAS 138786-67-1) Market, By Type
6. Global Pantoprazole Sodium (CAS 138786-67-1) Market, By Application
7. Global Pantoprazole Sodium (CAS 138786-67-1) Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Pantoprazole Sodium (CAS 138786-67-1) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/